INDIGO Launches Stable Reporter Cell Lines

• Direct contact technical support
• Find products for your research

In the world of cell-based assays, INDIGO Biosciences has long been recognized for its sensitive, all-inclusive reporter assay kits designed to accelerate drug discovery. Now, INDIGO has expanded its portfolio to meet the growing needs of customers in quality control and manufacturing environments with the launch of its new Stable Reporter Cell Lines.

While INDIGO’s transiently transfected assay kits have been a mainstay for researchers conducting early-stage compound screening where assay sensitivity is paramount, the introduction of Stable Reporter Cell Lines supports scientists working with routine, regulated workflows that demand consistency and reliability over time.

“These cell lines were developed with long-term reproducibility in mind,” said Dr. Andrew Woodman, Laboratory Director at INDIGO. “Our customers in manufacturing and quality control need tools that don’t just deliver results, they need them to deliver the same results, day in and day out.”

Purpose-Built for Routine Testing

Unlike transiently transfected assay systems, which offer rapid responsiveness ideal for exploratory studies, INDIGO’s Stable Reporter Cell Lines provide a stable platform for use in routine applications such as:

• Lot release and potency testing
• Assay development for GMP workflows
• Extended compound profiling and validation studies

The cell lines are fully optimized and quality-controlled by INDIGO’s team to ensure minimal variability, an essential feature for labs operating under strict regulatory oversight.

Complementing INDIGO’s Research-Focused Kits

What’s especially notable about this launch is how the Stable Reporter Cell Lines complement, INDIGO’s existing assay kit offerings. While research labs may continue to rely on the flexibility and sensitivity of INDIGO’s kits, Stable Reporter Cell Lines offer a reliable option for organizations that have moved from discovery to development and commercialization.

Bridging the Gap Between Research and Manufacturing

With this addition, INDIGO Biosciences has positioned itself as a provider of receptor and pathway-focused assay tools supporting scientific workflows from discovery through manufacturing release testing. The company’s Stable Reporter Cell Lines mark a thoughtful evolution in INDIGO’s product development strategy and signal a deep commitment to supporting companies across the full product lifecycle.

As assay reproducibility and standardization become increasingly critical in regulated environments, offerings like these Stable Reporter Cell Lines are expected to find a solid foothold among INDIGO’s global customer base.

About INDIGO Biosciences

INDIGO Biosciences is a leading provider of cell-based luciferase reporter assays for nuclear receptors, GPCRs, cytokine receptors, growth factor receptors, and more. The company is known for its deep scientific expertise, fast turnaround times, and comprehensive assay kits designed to simplify complex screening workflows.